Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver.
D002404:Catheterization; D000431:Ethanol / Q000009:adverse effects; D005227:Fatty Acids / Q000032:analysis / Q000097:blood; D005234:Fatty Liver / Q000139:chemically induced / Q000378:metabolism*; D006503:Hepatic Veins; D006801:Humans; D008099:Liver / Q000032:analysis / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008102:Liver Circulation; D009639:Norethandrolone / Q000494:pharmacology*; D010919:Placebos; D014280:Triglycerides / Q000097:blood / Q000378:metabolism*
D005227:Fatty Acids; D010919:Placebos; D014280:Triglycerides; D000431:Ethanol; D009639:Norethandrolone